Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
Rieger M, Mannucci PM, Kremer Hovinga JA, Herzog A, Gerstenbauer G, Konetschny C, Zimmermann K, Scharrer I, Peyvandi F, Galbusera M, Remuzzi G, Böhm M, Plaimauer B, Lämmle B, Scheiflinger F. Rieger M, et al. Among authors: remuzzi g. Blood. 2005 Aug 15;106(4):1262-7. doi: 10.1182/blood-2004-11-4490. Epub 2005 May 12. Blood. 2005. PMID: 15890682 Free article.
In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura.
Donadelli R, Banterla F, Galbusera M, Capoferri C, Bucchioni S, Gastoldi S, Nosari S, Monteferrante G, Ruggeri ZM, Bresin E, Scheiflinger F, Rossi E, Martinez C, Coppo R, Remuzzi G, Noris M; International Registry of Recurrent and Familial HUS/TTP. Donadelli R, et al. Among authors: remuzzi g. Thromb Haemost. 2006 Oct;96(4):454-64. Thromb Haemost. 2006. PMID: 17003922
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
Fakhouri F, Vernant JP, Veyradier A, Wolf M, Kaplanski G, Binaut R, Rieger M, Scheiflinger F, Poullin P, Deroure B, Delarue R, Lesavre P, Vanhille P, Hermine O, Remuzzi G, Grünfeld JP. Fakhouri F, et al. Among authors: remuzzi g. Blood. 2005 Sep 15;106(6):1932-7. doi: 10.1182/blood-2005-03-0848. Epub 2005 Jun 2. Blood. 2005. PMID: 15933059 Free article. Clinical Trial.
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.
Galbusera M, Bresin E, Noris M, Gastoldi S, Belotti D, Capoferri C, Daina E, Perseghin P, Scheiflinger F, Fakhouri F, Grünfeld JP, Pogliani E, Remuzzi G. Galbusera M, et al. Among authors: remuzzi g. Blood. 2005 Aug 1;106(3):925-8. doi: 10.1182/blood-2004-12-4885. Epub 2005 Apr 12. Blood. 2005. PMID: 15827129 Free article.
Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement.
Noris M, Bucchioni S, Galbusera M, Donadelli R, Bresin E, Castelletti F, Caprioli J, Brioschi S, Scheiflinger F, Remuzzi G; International Registry of Recurrent and Familial HUS/TTP. Noris M, et al. Among authors: remuzzi g. J Am Soc Nephrol. 2005 May;16(5):1177-83. doi: 10.1681/ASN.2005010086. Epub 2005 Mar 30. J Am Soc Nephrol. 2005. PMID: 15800115
Thrombotic thrombocytopenic purpura--then and now.
Galbusera M, Noris M, Remuzzi G. Galbusera M, et al. Among authors: remuzzi g. Semin Thromb Hemost. 2006 Mar;32(2):81-9. doi: 10.1055/s-2006-939763. Semin Thromb Hemost. 2006. PMID: 16575682 Review.
1,512 results